Havn Life Sciences Inc (HAVN.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 04/30
| 10-2021 | 07-2021 | 04-2021 | 01-2021 | 10-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,340 | 5,781 | 9,402 | 13,342 | 1,880 |
| Receivables | 376 | 274 | 210 | 163 | 121 |
| Inventories | 853 | 357 | N/A | N/A | N/A |
| TOTAL | $3,868 | $7,064 | $10,610 | $14,089 | $2,386 |
| Non-Current Assets | |||||
| PPE Net | 701 | 738 | 681 | N/A | N/A |
| Intangibles | 9,077 | 10,928 | 2,931 | 2,671 | 3,830 |
| Other Non-Current Assets | 774 | 18 | 18 | 6 | 0 |
| TOTAL | $10,552 | $11,684 | $3,630 | $2,676 | $3,830 |
| Total Assets | $14,420 | $18,748 | $14,240 | $16,765 | $6,216 |
| Liabilities | |||||
| Current Liabilities | |||||
| TOTAL | $671 | $629 | $715 | $1,012 | $822 |
| Non-Current Liabilities | |||||
| TOTAL | $293 | $310 | $325 | $0 | $0 |
| Total Liabilities | $964 | $939 | $1,040 | $1,012 | $822 |
| Shareholders' Equity | |||||
| Common Shares | 45,521 | 44,224 | 36,997 | 25,364 | 8,754 |
| Retained earnings | -39,310 | -33,392 | -30,421 | -19,422 | -6,262 |
| Other shareholders' equity | 6,738 | 6,470 | 6,117 | 9,098 | 2,901 |
| TOTAL | $13,456 | $17,809 | $13,200 | $15,752 | $5,393 |
| Total Liabilities And Equity | $14,420 | $18,748 | $14,240 | $16,765 | $6,216 |